LNPK

Endoplasmic reticulum junction formation protein lunapark · Q9C0E8 · LNPK on Sugi Atlas →

0 patent compounds predicted against LNPK, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to LNPK by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Effect of Topical Melatonin Application on Dental Implant Osseointegration and Marginal Bone Level PHASE3UNKNOWN
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin PHASE2/PHASE3UNKNOWN
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity PHASE2RECRUITING
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria PHASE2COMPLETED
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer PHASE2WITHDRAWN
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula PHASE2COMPLETED
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia PHASE2WITHDRAWN
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors PHASE1COMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Evaluation of the Clinical Course of NERD and Assessment of the Esophageal Mucosa Resistance nanACTIVE_NOT_RECRUITING
Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples. nanUNKNOWN
Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation nanUNKNOWN
Profiling Gingival Crevicular Fluid β-Catenin Level With 8-OHdG and Total Antioxidants Capacity During Healing of Periodontal Pockets: A 3-month Clinical Trial nanNOT_YET_RECRUITING
The Roles of Neutrophil Elastase in Lung Cancer nanUNKNOWN
The Gut-Skin Axis Integrity in Psoriatic Patients nanUNKNOWN
Open-Label Study of Omega 3 Oil Supplementation for Aging-Related Cognitive Decline nanCOMPLETED
Statin Therapy and COVID-19 Infection nanCOMPLETED
Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease nanRECRUITING
Effect of Protein on Endoplasmic Reticulum Stress nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
The Activation of Hippo Pathway in Nasal Polyps nanUNKNOWN
Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a LNPK binder may also engage these)

ProteinNameSimilarity
Q5R891 1.000 Q5R891 →
Q7TQ95 1.000 Q7TQ95 →
Q6DFJ8 0.999 Q6DFJ8 →
Q28HF6 0.997 Q28HF6 →
Q6PFM4 0.997 Q6PFM4 →
Q7ZU80 0.996 Q7ZU80 →
Q1KKR9 0.996 Q1KKR9 →
Q1KKT4 0.991 Q1KKT4 →
Q69ZZ6 0.989 Q69ZZ6 →
SMARCC2 SWI/SNF complex subunit SMARCC2 0.988 landscape →
Q2IBA2 0.987 Q2IBA2 →
Q00PJ1 0.987 Q00PJ1 →
Q9ULJ8 0.986 Q9ULJ8 →
A0M8T5 0.986 A0M8T5 →
Q61029 0.986 Q61029 →
Q09YK4 0.986 Q09YK4 →
Q96D71 0.985 Q96D71 →
Q28E45 0.985 Q28E45 →
Q5R789 0.985 Q5R789 →
Q09YM8 0.985 Q09YM8 →
Q8WZ74 0.985 Q8WZ74 →
NFRKB Nuclear factor related to kappa-B-binding protein 0.985 landscape →
A0M8S4 0.985 A0M8S4 →
Q9Z136 0.985 Q9Z136 →
B9EJA2 0.984 B9EJA2 →
Q2QLF8 0.984 Q2QLF8 →
Q07DV1 0.984 Q07DV1 →
Q2IBD4 0.984 Q2IBD4 →
Q02225 0.984 Q02225 →
Q9JHD2 0.984 Q9JHD2 →